A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

Mt Sinai Comprehensive Cancer Center, Miami Beach, Florida, United States

Mayo Clinic, Rochester, Minnesota, United States

Summit Medical Group, Florham Park, New Jersey, United States

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States

Texas Oncology - Sammons Cancer Center, Dallas, Texas, United States

IRCCS Ospedale San Raffaele, Milan, Italy

Azienda Ospedaliero Universitaria Maggiore Della Carità, Novara, Italy

Azienda Ospedale Università Padova, Padova, Italy

MD Anderson Cancer Center Madrid, Madrid, Spain

Hospital Universitario Fundación Jiménez Díaz - START MADRID, Madrid, Spain